🇺🇸 FDA
Patent

US 9221772

Synthesis of syrbactin proteasome inhibitors

granted A61KA61K38/06A61K45/06

Quick answer

US patent 9221772 (Synthesis of syrbactin proteasome inhibitors) held by The Regents of the University of California expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/06, A61K45/06, A61P, A61P29/00